Taro Pharmaceuticals Inc. Product Recall (2020-07-20)

Starting date:
July 20, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-73615

Last updated:

Summary

  • Product: A. Dermovate Cream B. Taro-Clobetasol Cream USP, 0.05%
  1. Dermovate Cream
  2. Taro-Clobetasol Cream USP, 0.05%

Reason

The content uniformity may be out of specification in the affected lots.

Depth of distribution

Wholesalers

Affected products

Dermovate Cream

DIN, NPN, DIN-HIM

DIN 02213265

Dosage form

Cream

Strength

Clobetasol Propionate, 0.05%

Lot or serial number

AB40179

Companies

Recalling Firm
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA

Taro-Clobetasol Cream USP, 0.05%

DIN, NPN, DIN-HIM

DIN 02245523

Dosage form

Cream

Strength

Clobetasol Propionate, 0.05%

Lot or serial number

AB28534
AB27927

Companies

Recalling Firm
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA